{
  "report_rows": [
    {
      "kpi": "Q2 non-GAAP operating EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$0.80 vs. cons $0.79",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 total revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.70B vs. cons $2.66B",
      "confidence": "LOW"
    },
    {
      "kpi": "PSE&G regulated net income",
      "prediction": "IN-LINE",
      "answer": "pred ~$340M vs. cons ~$335M",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 operating EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide $4.28-$4.40 (mid $4.34) vs. cons $4.36 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Long-term operating EPS CAGR",
      "prediction": "UNCHANGED",
      "answer": "guide 6-8% vs. cons ~7% (through 2030)",
      "confidence": "HIGH"
    },
    {
      "kpi": "5-yr regulated capex plan",
      "prediction": "UNCHANGED",
      "answer": "guide $22.5-25.5B vs. cons ~$24B (2026-2030)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 0.8,
  "day1_confidence": "LOW",
  "day5_residual_pct": 0.5,
  "day5_path": "STABILIZE",
  "day5_rationale": "Decoupled, ~90% regulated model means the seasonally-small Q2 print is low-drama; an in-line EPS with FY guidance merely reaffirmed (no top-half narrowing) gives little upward-revision fuel, but out-period math is intact (6-8% CAGR, $22.5-25.5B capex) so estimates hold rather than get cut. Stock already sold off ~8% into the print and underperformed XLU, so expectations are reset \u2014 a modest relief that stabilizes rather than a follow-through rally; the swing risk is NJ EO1/BPU business-model and PJM RBA cost-allocation commentary.",
  "day5_confidence": "LOW"
}